Otsuka Holdings Co Ltd
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Otsuka Holdings Co Ltd in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Otsuka Holdings Co Ltd.
Recent articles on PMLiVE featuring Otsuka Holdings Co Ltd
Mental illness tech platform wins the pharma firm’s US pitch challenge
Soluble sensor tracks drug ingestion and shares information with HCPs
They join Alexion, Chiesi, Janssen, Novartis, Otsuka and Takeda
Wants more data on its combination of Abilify and Proteus sensor and pill
Sees off competition from AbbVie, Bayer, Novartis and Pfizer
Positive opinion for Otsuka comes just before rare disease awareness day
Deal for US biotech is valued at $3.5bn
Schizophrenia treatment is a key product to help Lundbeck replace lost Cipralex sales
On course as successor to antipsychotic Abilify
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology